(Q34130459)
Statements
1 reference
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin (English)
1 reference
Pieter Sonneveld
1 reference
Gabriele Buda
1 reference
Robert Z Orlowski
1 reference
Deborah Ricci
1 reference
C Chris Huang
1 reference
Reyna Favis
1 reference
Nadine Cohen
1 reference
Sen H Zhuang
1 reference
Jean-Luc Harousseau
1 reference
Joan Bladé
1 reference
8 June 2010
1 reference
1 reference
89
1 reference
11
1 reference
1133-1140
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference